HB 1416

  • Oklahoma House Bill
  • 2025 Regular Session
  • Introduced in House Mar 04, 2025
  • Passed House Mar 03, 2025
  • Senate
  • Governor

Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.

Votes


No votes to display

Actions


Apr 01, 2025

Senate

Second Reading referred to Health and Human Services Committee then to Appropriations Committee

Mar 04, 2025

House

Engrossed, signed, to Senate

Senate

First Reading

Mar 03, 2025

House

Coauthored by Representative(s) Fugate

House

General Order

House

Amended

House

Title stricken

House

Third Reading, Measure passed: Ayes: 90 Nays: 7

House

Referred for engrossment

Feb 26, 2025

House

CR; Do Pass, amended by committee substitute Health and Human Services Oversight Committee

Feb 05, 2025

House

Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health

House

Authored by Senator Rosino (principal Senate author)

Feb 04, 2025

House

Referred to Public Health

House

Second Reading referred to Health and Human Services Oversight

Feb 03, 2025

House

Authored by Representative West (Josh)

House

First Reading

Bill Text

Bill Text Versions Format
Introduced PDF
House Committee Substitute PDF
Floor (House) PDF
Engrossed PDF
1 Floor Amendment by CALDWELL PDF
Proposed Committee Substitute (full committee) 1 PDF

Related Documents

Document Format
House Committee Report PDF
House Policy Committee Report PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Oklahoma Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.